Vascular effects of deletion of melanocortin-4 receptors in rats

Physiological Reports

Volumn 1, Issue 6, 2013, Pages 1-7

  Stepp, David W ^a   Osakwe, Christabell C ^a   de Chantemele, Eric J Belin ^a   Mintz, James D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Blood pressure; Obesity; Vascular

Indexed keywords

INSULIN; LEPTIN; MECAMYLAMINE; MELANOCORTIN 4 RECEPTOR; PHENYLEPHRINE;

ADULT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ELECTROMYOGRAPHY; GENE DELETION; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC REGULATION; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN EXPRESSION; RAT; SYMPATHETIC TONE; TELEMETRY;

EID: 85008870883     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.146     Document Type: Article

References (28)

1. Ali, M. I., P. Ketsawatsomkron, E. J. Belin de Chantemele, J. D. Mintz, K. Muta, C. Salet, et al. 2009. Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ. Res. 105: 1013–1022.
2. Alonso-Galicia, M., M. W. Brands, D. H. Zappe, and J. E. Hall. 1996. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28: 1047–1054.
3. Belin de Chantemele, E. J., K. Muta, J. Mintz, M. L. Tremblay, M. B. Marrero, D. J. Fulton, et al. 2009. Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. Circulation 120: 753–763.
4. Belin de Chantemele, E. J., M. I. Ali, J. D. Mintz, W. E. Rainey, M. L. Tremblay, D. J. Fulton, et al. 2012. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity. Hypertension 60: 1273–1279.
5. do Carmo, J. M., L. S. Tallam, J. V. Roberts, E. L. Brandon, J. Biglane, A. A. da Silva, et al. 2009. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297: R803–R812.
6. D’Angelo, G., A. A. Elmarakby, D. M. Pollock, and D. W. Stepp. 2005. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 46: 806–811.
7. D’Angelo, G., J. D. Mintz, J. E. Tidwell, A. M. Schreihofer, D. M. Pollock, and D. W. Stepp. 2006. Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats. Hypertension 48: 1109–1115.
8. Greenfield, J. R. 2011. Melanocortin signalling and the regulation of blood pressure in human obesity. J. Neuroendocrinol. 23: 186–193.
9. Greenfield, J. R., J. W. Miller, J. M. Keogh, E. Henning, J. H. Satterwhite, G. S. Cameron, et al. 2009. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360: 44–52.
10. Hall, J. E., M. W. Brands, and J. R. Henegar. 1999. Mechanisms of hypertension and kidney disease in obesity. Ann. N. Y. Acad. Sci. 892: 91–107.
11. Hall, J. E., D. A. Hildebrandt, and J. Kuo. 2001. Obesity hypertension: role of leptin and sympathetic nervous system. Am. J. Hypertens. 14: 103S–115S.
12. Hall, J. E., and A. A. da Silva, J. M. do Carmo, J. Dubinion, S. Hamza, S. Munusamy, et al. 2010. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 285: 17271–17276.
13. Huszar, D., C. A. Lynch, V. Fairchild-Huntress, J. H. Dunmore, Q. Fang, L. R. Berkemeier, et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131–141.
14. Kuo, J. J., A. A. daSilva, L. S. Tallam, and J. E. Hall. 2004. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension 43: 370–375.
15. Osmond, J. M., J. D. Mintz, and D. W. Stepp. 2010. Preventing increased blood pressure in the obese Zucker rat improves severity of stroke. Am. J. Physiol. 299: H55–H61.
16. Rahmouni, K., W. G. Haynes, D. A. Morgan, and A. L. Mark. 2003. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J. Neurosci. 23: 5998–6004.
17. Romanko, O. P., and D. W. Stepp. 2005. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. Am. J. Physiol. 289: H2097–H2102.
18. Romanko, O. P., M. I. Ali, J. D. Mintz, and D. W. Stepp. 2009. Insulin resistance impairs endothelial function but not adrenergic reactivity or vascular structure in fructose-fed rats. Microcirculation 16: 414–423.
19. Sayk, F., D. Heutling, C. Dodt, K. A. Iwen, J. P. Wellhoner, S. Scherag, et al. 2010. Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. J. Clin. Endocrinol. Metab. 9 5: 1998–2002.
20. Scherrer, U., and C. Sartori. 1997. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96: 4104–4113.
21. Schreihofer, A. M., C. D. Hair, and D. W. Stepp. 2004. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2 88: R253–R261.
22. Schreihofer, A. M., D. A. Mandel, S. C. Mobley, and D. W. Stepp. 2007. Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. Am. J. Physiol. 293: H2543–H2549.
23. da Silva, A. A., J. J. Kuo, and J. E. Hall. 2004. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43: 1312–1317.
24. Stepp, D. W., and T. N. Tulenko. 1994. Alterations in basal and serotonin-stimulated calcium permeability and vasoconstriction in atherosclerotic aorta. Arterioscler. Thromb. 1 4: 1854–1859.
25. Tallam, L. S., D. E. Stec, M. A. Willis, A. A. da Silva, and J. E. Hall. 2005. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46: 326–332.
26. Tallam, L. S., A. A. da Silva, and J. E. Hall. 2006. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58–64.
27. Van Bergen, P., P. M. Janssen, P. Hoogerhout, D. J. De Wildt, and D. H. Versteeg. 1995. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship. Eur. J. Pharmacol. 294: 795–803.
28. Van Boxtel, R., B. Vroling, P. Toonen, I. J. Nijman, H. van Roekel, M. Verheul, et al. 2011. Systematic generation of in vivo G protein-coupled receptor mutants in the rat. Pharmacogenomics J. 11: 326–336.